Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis

Clinical trial NCT05722964 · COMPLETED

Trial details

NCT number: NCT05722964
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-03-29
Primary completion: 2024-08-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.